Literature DB >> 11067911

Competitive displacement of pT alpha by TCR-alpha during TCR assembly prevents surface coexpression of pre-TCR and alpha beta TCR.

S Trop1, M Rhodes, D L Wiest, P Hugo, J C Zúñiga-Pflücker.   

Abstract

During alphabeta T cell development, CD4(-)CD8(-) thymocytes first express pre-TCR (pTalpha/TCR-beta) before their differentiation to the CD4(+)CD8(+) stage. Positive selection of self-tolerant T cells is then determined by the alphabeta TCR expressed on CD4(+)CD8(+) thymocytes. Conceivably, an overlap in surface expression of these two receptors would interfere with the delicate balance of thymic selection. Therefore, a mechanism ensuring the sequential expression of pre-TCR and TCR must function during thymocyte development. In support of this notion, we demonstrate that expression of TCR-alpha by immature thymocytes terminates the surface expression of pre-TCR. Our results reveal that expression of TCR-alpha precludes the formation of pTalpha/TCR-beta dimers within the endoplasmic reticulum, leading to the displacement of pre-TCR from the cell surface. These findings illustrate a novel posttranslational mechanism for the regulation of pre-TCR expression, which may ensure that alphabeta TCR expression on thymocytes undergoing selection is not compromised by the expression of pre-TCR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067911     DOI: 10.4049/jimmunol.165.10.5566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  How alpha beta T cells deal with induced TCR alpha ablation.

Authors:  B Polic; D Kunkel; A Scheffold; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 2.  Transcription factors and target genes of pre-TCR signaling.

Authors:  Cristina López-Rodríguez; Jose Aramburu; Rosa Berga-Bolaños
Journal:  Cell Mol Life Sci       Date:  2015-02-22       Impact factor: 9.261

3.  Thymic negative selection is functional in NOD mice.

Authors:  Michael Mingueneau; Wenyu Jiang; Markus Feuerer; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2012-02-13       Impact factor: 14.307

4.  The timing of TCR alpha expression critically influences T cell development and selection.

Authors:  Troy A Baldwin; Michelle M Sandau; Stephen C Jameson; Kristin A Hogquist
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

5.  Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection.

Authors:  Jonathan S Maltzman; Lisa Kovoor; James L Clements; Gary A Koretzky
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

6.  Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate.

Authors:  Annette I Garbe; Andreas Krueger; Fotini Gounari; Juan Carlos Zúñiga-Pflücker; Harald von Boehmer
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

7.  An endoplasmic reticulum retention function for the cytoplasmic tail of the human pre-T cell receptor (TCR) alpha chain: potential role in the regulation of cell surface pre-TCR expression levels.

Authors:  Y R Carrasco; A R Ramiro; C Trigueros; V G de Yébenes; M García-Peydró; M L Toribio
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

8.  The biological activity of natural and mutant pTalpha alleles.

Authors:  D Gibbons; N C Douglas; D F Barber; Q Liu; R Sullo; L Geng; H J Fehling; H von Boehmer; A C Hayday
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

9.  TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes.

Authors:  Monica W L Leung; Shiqian Shen; Juan J Lafaille
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

10.  Pre-TCRalpha and TCRalpha are not interchangeable partners of TCRbeta during T lymphocyte development.

Authors:  Christine Borowski; Xiaoyan Li; Iannis Aifantis; Fotini Gounari; Harald von Boehmer
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.